File Archive - Addiction Documents - Baclofen in the management of inhalant withdrawal: a case series (2008)

News Groups Blog Forum Chat Video Audio Images Documents Wiki Home

		Drugs Forum > File Archive > Documents > VARIOUS DRUG RELATED TOPICS > Addiction Documents
Baclofen in the management of inhalant withdrawal: a case series (2008)

Tags

FAQ n Rules

Mark Forums Read

Notices

Create a FREE account now to get access to more forums, more videos, more music, more documents, more images, more reviews, more news about drugs and much more functionality.
Start posting now, join our groups or create your unique profile.

links

Addiction Documents

Documents about addiction

New entries announced in forum Recovery and addiction

Allowances: 4.88 Mbytes/3.52 Mbytes used

[RSS Feed]

Entries

Baclofen in the management of inhalant withdrawal: a case series (2008)

Left click: open entry/Right click: save entry

Primary Care Companion to the Journal of Clinical Psychiatry 2008;10(1):48-51

Muralidharan K, Rajkumar RP, Mulla U, Nayak RB, Benegal V.

Introduction: Abuse of inhalants and solvents is a significant public health problem. There is no specific treatment for inhalant withdrawal.Objective: To study the effect of baclofen in treating craving and withdrawal symptoms in patients with inhalant dependence.Case Reports: Case studies of 3 young male patients with DSM-IV diagnoses of inhalant dependence treated in an inpatient setting with baclofen are presented. All patients had nonspecific withdrawal symptoms in the form of irritability, insomnia, and craving. Baclofen was given in doses up to 50 mg/day and was continued throughout the period of hospitalization.Discussion: All patients reported significant reduction in withdrawal symptoms within 48 hours of treatment and were free of symptoms for the duration of their hospital stay. One patient continued the medication as an outpatient and has remained abstinent to date. Baclofen was well tolerated by all patients. Our results suggest that baclofen may be an effective treatment modality in this patient population. These effects are possibly due to the agonistic action of baclofen at gamma-aminobutyric acid B receptors in the ventral tegmental area.

Discussion Thread

Category Addiction Documents

Submitted by Jatelka

05-02-2009
121.80 Kbytes Hits 64

Category

Forum Jump

Sitelinks:	Site Functions:
Homepage Wiki Documents Image Gallery Audio Video Forum Blog Groups News	Site Rules Frequently Asked Questions Register to Participate Did you forget your password? All Threads

All times are GMT +1. The time now is 18:54.